Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT
Annals of Hematology · 12.05.2026 · 105 (7)
DOI: 10.1007/s00277-026-07063-4 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Hematology, online erschienen am 12.05.2026. Verfasst von Víctor Torrecillas-Mayayo und 21 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: POEMS Syndrome, B-Cell Maturation Antigen, Immunotherapy, Adoptive. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundació Institució dels Centres de Recerca de Catalunya.
Abstract (Originalsprache)
Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, and Skin changes (POEMS) syndrome is a rare plasma cell disorder with diverse multisystem manifestations. Autologous stem cell transplantation (ASCT) is the preferred front-line therapy when feasible, but relapsed/refractory (RR) cases after ASCT failure lack effective salvage options. B-cell maturation antigen (BCMA)-directed CAR-T cell therapy has revolutionised multiple myeloma (MM) treatment. Given the shared BCMA expression on clonal plasma cells between MM and POEMS, CAR-T cell therapy is also a biologically compelling strategy for POEMS syndrome [1]. However, there are only two previous case reports of CAR-T cell therapy in POEMS [3,4], none involving patients with prior ASCT failure. We report a 54-year-old male with RR-POEMS progressing after two previous ASCT failures who received an academic point-of-care BCMA-directed CAR-T cell therapy (ARI0002h) via fractionated infusion. No cytokine release syndrome (CRS) or neurotoxicity (ICANS) occurred. At 3 months, the patient achieved a measurable residual disease (MRD)-negative complete haematological response (CR H ) by Next Generation Flow (NGF) with a sensitivity of 10⁻⁶ and a radiological CR. Responses have been sustained for 10 months. Serum BCMA (sBCMA) levels declined dynamically in parallel with haematological response, suggesting potential utility as a novel monitoring biomarker in POEMS. This case supports BCMA-directed CAR-T therapy as a safe and effective salvage strategy in RR-POEMS following ASCT failure, even in an aggressive disease context. Clinical trial registration: Not aplicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
- Hospital Clínic de Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain. CFERNAN1@clinic.cat.
Förderung
- Fundació Institució dels Centres de Recerca de Catalunya
Zitieren
APA
Torrecillas-Mayayo, V., Oliver-Caldes, A., Martínez-Cibrian, N., Albiol, N., Rodríguez-Lobato, L. G., Español-Rego, M., Ortiz-Maldonado, V., Rosiñol, L., Tovar, N., Navarro-Velasquez, S., Charry, P., Munárriz, D., Mateos, J. M., Jimenez-Mira, C., Moreno, D. F., Montoro, M., Ayora, P., Delgado, J., Juan, M., …, & Fernández de Larrea, C. (2026). Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT. Annals of Hematology, 105(7). https://doi.org/10.1007/s00277-026-07063-4
Vancouver
Torrecillas-Mayayo V, Oliver-Caldes A, Martínez-Cibrian N, Albiol N, Rodríguez-Lobato LG, Español-Rego M, et al. Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT. Annals of Hematology. 2026;105(7). doi:10.1007/s00277-026-07063-4
BibTeX
@article{TorrecillasMayayo2026,
author = {Torrecillas-Mayayo, Víctor and Oliver-Caldes, Aina and Martínez-Cibrian, Nuria and Albiol, Nil and Rodríguez-Lobato, Luis Gerardo and Español-Rego, Marta and Ortiz-Maldonado, Valentín and Rosiñol, Laura and Tovar, Natalia and Navarro-Velasquez, Sergio and Charry, Paola and Munárriz, Daniel and Mateos, Jose Miguel and Jimenez-Mira, Carlos and Moreno, David F and Montoro, Mercedes and Ayora, Pilar and Delgado, Julio and Juan, Manel and González-Navarro, Azucena and Cibeira, Maria Teresa and Fernández de Larrea, Carlos},
title = {Academic BCMA CAR-T (ARI0002h) achieves MRD-negative remission with sBCMA biomarker response in relapsed POEMS syndrome after double ASCT},
journal = {Annals of Hematology},
year = {2026},
volume = {105},
number = {7},
doi = {10.1007/s00277-026-07063-4}
}
EUVIMED